Phage Therapy in Bacterial Pneumonia Models: A Systematic Review and Meta-Analysis.

Area of Science:

• Microbiology
• Infectious Diseases
• Therapeutics

Background:

• Bacterial pneumonia poses a significant health challenge, with limited treatment options.
• The efficacy of phage therapy in treating bacterial pneumonia remains largely undetermined.
• Bacteriophages offer a potential alternative or adjunct to conventional antibiotic treatments.

Approach:

• A systematic literature search was conducted using MeSH terms and Boolean operators.
• Studies were selected based on PRISMA guidelines for eligibility.
• Meta-analysis involved calculating Odds Ratios (OR) with 95% confidence intervals and assessing heterogeneity.

Key Points:

• Phage therapy demonstrated a significant reduction in mortality rates in preclinical bacterial pneumonia models at 24 hours, 7 days, and 10 days post-treatment (ORs ranging from 0.04 to 0.11).
• A non-significant reduction in mortality was observed at 48 hours.
• Publication bias was qualitatively assessed using funnel plots.

Conclusions:

• Phage therapy plays a significant role in reducing mortality in preclinical models of bacterial pneumonia.
• The findings support the potential of phage therapy as an effective intervention for bacterial pneumonia.
• Further research is warranted to explore the clinical applications of phage therapy in pneumonia treatment.